Zelira Therapeutics Ltd News

Zelira Therapeutics Ltd: Appendix 4E and Financial Report to Shareholders

Aug 28 11:35 · Announcements

Zelira Therapeutics Secures US FDA Guidance for Autism Spectrum Therapy; Shares Jump 7%

MT NewswiresAug 22 10:32

Zelira Therapeutics Jumps 25% After Securing Australian Patents for Autism Formulations

MT NewswiresJul 16 10:12

Zelira Therapeutics Secures US FDA Guidance for Autism Spectrum Disorder Therapy Program; Shares Surge 24%

MT NewswiresJul 11 11:44

Zelira Therapeutics Receives $1.4 Million Unsecured Loan From Chairman

MT NewswiresJul 4 13:29

Zelira Therapeutics Obtains $1.4 Million Loan From Chairman

MT NewswiresJul 1 12:46

Zelira Therapeutics Receives Third-Tranche of Funding for HOPE Clinical Trials

MT NewswiresMay 23 11:22

Zelira Therapeutics Receives AU$919,000 Funding Under Australian Government's R&D Tax Incentive Scheme

MT NewswiresApr 15 09:48

Zelira Therapeutics Secures Grant Funding for Cannabinoid Product

MT NewswiresJan 8 10:14

It's Unlikely That The CEO Of Zelira Therapeutics Limited (ASX:ZLD) Will See A Huge Pay Rise This Year

Yahoo FinanceNov 9, 2023 04:38